Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 456

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 5
Chunk 456
---
 2024. From 2015 to 2020, Ms. Stockwell was Managing Member of Bright Green Innovations, LLC, a pioneering
plant-based pharmaceutical research company recognized for its compliance with federal legal standards. In this role, Ms. Stockwell expertly
managed business, industry, and medical research relationships. In addition to her leadership roles, Ms. Stockwell has also served as
a director at a hospital, where she spearheaded fundraising initiatives advocating for the use of natural additives as a safer alternative
to opioids. Her dedica tion extends to her sponsorship of biomedical research and clinical trials, particularly in the area of plant-based
bio-identical hormone replacement. Ms. Stockwell’s commitment to healthcare innovation is further demonstrated by her membership
in the Association for Healthcare Philanthropy (AHP). Ms. Stockwell is also actively involved in advancing the professional development
of women in the life sciences through her membership in the BioIndustry Association (BIA), where she focuses on scholarship opportunities.
Additionally, she is a member of the National Breast Cancer Coalition, reflecting her commitment to impactful healthcare advocacy.

Glenn Worman has been our Chief Financial
Officer since July 2024. Mr. Worman has been a Partner in the New York office of SeatonHill Partners, LP since November 2022.
He has served as CFO of Orion Innovations Inc. since February 2025. Mr. Worman served as Chief Financial Officer of Insight Acquisition
Corp., a special purpose acquisition company, from April 2024 until the completion of its business combination with Alpha Modus,
Corp. in December 2024. Between 2015 and 2022, Mr. Worman served as the CFO and President of National Holdings Corporation. From
2011 to 2015, he served as the Chief Financial Officer for the Americas for ICAP, plc. Prior to ICAP, plc, Mr. Worman held senior
positions at, among other companies, Deutsche Bank, Morgan Stanley, and Merrill Lynch. Mr. Worman is an accomplished and diverse
financial services executive with a history of providing strong, effective leadership and developing and executing strategy across a spectrum
of businesses. With nearly four decades of experience, he is adept at organizational analysis and implementing change, ensuring proper
controls and sources of liquidity are in place, and advising executive management on business direction. Mr. Worman’s prior
experience in senior finance and chief operating officer positions in corporate